510(k) Report

510(k) · Cleared

Recalled · 2003

TDX C-Reactive Protein

K854542510(k) TraditionalCleared Jan 24, 198672-day reviewClass II21 CFR 866.5270Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Abbott Laboratories · DCK C-Reactive Protein, Antigen, Antiserum, And Control

Cleared on Jan 24, 1986 after a 72-day review. FDA has not posted a summary or statement for it, so its predicates are not known. It has been recalled once.

Decided
Jan 24, 1986
Review
72 days
Class
Class II
Product code
DCK
Recalls
1
Predicates
0

FDA has not posted a summary or statement for it, so its predicates are not known.

FIG. 1 — Lineage of K854542Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DCK? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DCK device

  1. #1 K242170 K-ASSAY CRP (Ver.2)score 9.2 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA has not posted a summary or statement for it, so its predicates are not known.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Dec 5, 2003Not classifiedZ-0507-04OtherThe reagent package inserts for the products contain incorrect information in the Specific Performance Characteristics section. Accuracy by Correlation table

No ancestor or descendant has a Class I recall.

How does its category compare?

All DCK devices

DCK C-Reactive Protein, Antigen, Antiserum, And Control: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DCK

1in 2025

2011: 12012: 12015: 22016: 12017: 12019: 22020: 12022: 12025: 1
2007high 2 (2015) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DCK

Too few DCK 510(k)s in any year since 2007 to give a median.

Recalls per year · DCK

1in 2024

2008: 12009: 12013: 12016: 12024: 1
2007high 1 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DCK

1in 2021

2008: 12011: 12012: 12014: 12021: 1
2007high 1 (2008) · low 0 (2007)2025

MAUDE reports naming product code DCK, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—11
20090—10
20100—00
20111—01
20121—01
20130—10
20140—01
20152—00
20161—10
20171—00
20180—00
20192—00
20201—00
20210—01
20221—00
20230—00
20240—10
20251—00
20260—0—
Cite this page

510(k) Report. “K854542: TDX C-Reactive Protein.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K854542

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026